ESCO2

Chr 8AR

establishment of sister chromatid cohesion N-acetyltransferase 2

Also known as: 2410004I17Rik, EFO2, EFO2p, JHS, RBS, hEFO2

This gene encodes a protein that may have acetyltransferase activity and may be required for the establishment of sister chromatid cohesion during the S phase of mitosis. Mutations in this gene have been associated with Roberts syndrome. [provided by RefSeq, Jul 2008]

Primary Disease Associations & Inheritance

Juberg-Hayward syndromeMIM #216100
AR
Roberts-SC phocomelia syndromeMIM #268300
AR
0
Active trials
91
Pathogenic / LP
493
ClinVar variants
14
Pubs (1 yr)
0.4
Missense Z
0.83
LOEUF
Clinical SummaryESCO2
🧬
Gene-Disease Validity (ClinGen)
Roberts-SC phocomelia syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
91 Pathogenic / Likely Pathogenic· 185 VUS of 493 total submissions
📖
GeneReview available — ESCO2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.83LOEUF
pLI 0.000
Z-score 2.24
OE 0.54 (0.360.83)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.41Z-score
OE missense 0.93 (0.851.03)
281 obs / 300.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.54 (0.360.83)
00.351.4
Missense OE0.93 (0.851.03)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 15 / 27.7Missense obs/exp: 281 / 300.9Syn Z: 0.56
DNLOF
DN
0.7036th %ile
GOF
0.3193th %ile
LOF
0.4430th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
LOF56% of P/LP variants are LoF

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

493 submitted variants in ClinVar

Classification Summary

Pathogenic56
Likely Pathogenic35
VUS185
Likely Benign208
Benign4
Conflicting5
56
Pathogenic
35
Likely Pathogenic
185
VUS
208
Likely Benign
4
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
22
0
34
0
56
Likely Pathogenic
29
2
4
0
35
VUS
0
162
15
8
185
Likely Benign
0
1
88
119
208
Benign
0
0
4
0
4
Conflicting
5
Total51165145127493

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

ESCO2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

ESCO2-related Roberts syndrome

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. DisordersEyeSkinSkeletal
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence